ES2063329T3 - Inhidores de fucosidasa. - Google Patents

Inhidores de fucosidasa.

Info

Publication number
ES2063329T3
ES2063329T3 ES90870105T ES90870105T ES2063329T3 ES 2063329 T3 ES2063329 T3 ES 2063329T3 ES 90870105 T ES90870105 T ES 90870105T ES 90870105 T ES90870105 T ES 90870105T ES 2063329 T3 ES2063329 T3 ES 2063329T3
Authority
ES
Spain
Prior art keywords
fucosidase
inhidors
beta
homofuconojirimicina
deoximanojirimicinas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90870105T
Other languages
English (en)
Inventor
George William John Dep Fleet
Sung Keon Namgoong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2063329T3 publication Critical patent/ES2063329T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA LA SINTESIS DE NUEVOS INHIBIDORES DE LA FUCOSIDASA: (BETA) - L HOMOFUCONOJIRIMICINA Y LAS DEOXIMANOJIRIMICINAS 1-(BETA) - C SUBSTITUIDAS RELACIONADAS.
ES90870105T 1989-06-27 1990-06-26 Inhidores de fucosidasa. Expired - Lifetime ES2063329T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/371,943 US5100797A (en) 1989-06-27 1989-06-27 Fucosidase inhibitors

Publications (1)

Publication Number Publication Date
ES2063329T3 true ES2063329T3 (es) 1995-01-01

Family

ID=23466049

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90870105T Expired - Lifetime ES2063329T3 (es) 1989-06-27 1990-06-26 Inhidores de fucosidasa.

Country Status (8)

Country Link
US (1) US5100797A (es)
EP (1) EP0406211B1 (es)
JP (1) JP2927893B2 (es)
AT (1) ATE103594T1 (es)
CA (1) CA2019798C (es)
DE (1) DE69007695T2 (es)
DK (1) DK0406211T3 (es)
ES (1) ES2063329T3 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276120A (en) * 1991-05-30 1994-01-04 The Scripps Research Institute Process for forming omega-deuxy-azasugars
WO1992021657A1 (en) * 1991-05-30 1992-12-10 The Scripps Research Institute Omega-deoxy-azasugars
ES2228452T3 (es) * 1999-02-02 2005-04-16 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai 2-amino-5-metilpiperidin-3,4-dioles 2n-sustituidos o no sustituidos y procedimientos para la preparacion de los mismos.
ES2302697T3 (es) * 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales.
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
KR20090040906A (ko) 2006-08-02 2009-04-27 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 리포솜 치료
KR20090057035A (ko) * 2006-08-21 2009-06-03 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 치료를 위한 병용 요법
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体
TWI558397B (zh) * 2010-01-28 2016-11-21 雷普特製藥有限公司 以受體關連蛋白（ｒａｐ）胜肽－岩藻醣苷水解酶抑制劑共軛物治療肝腫瘤之方法
AR105540A1 (es) 2015-07-30 2017-10-11 Raptor Pharmaceuticals Inc Inhibidores de fucosidasas
CN112843081B (zh) * 2021-02-02 2022-07-05 四川大学 一种dna四面体-白藜芦醇复合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2848117A1 (de) * 1978-11-06 1980-05-14 Bayer Ag Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel
US4999360A (en) * 1987-12-21 1991-03-12 Monsanto Company Method of inhibiting virus
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
US4861892A (en) * 1988-02-12 1989-08-29 G. D. Searle & Co. Method for synthesis of deoxymannojirimycin
US4992460A (en) * 1989-09-08 1991-02-12 Monsanto Company Bicyclic tetrahydroxylated pyrrolizidines
US4996329A (en) * 1989-10-20 1991-02-26 Monsanto Company Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation

Also Published As

Publication number Publication date
ATE103594T1 (de) 1994-04-15
DE69007695D1 (de) 1994-05-05
DE69007695T2 (de) 1994-08-11
EP0406211A2 (en) 1991-01-02
JPH0331260A (ja) 1991-02-12
CA2019798A1 (en) 1990-12-27
EP0406211A3 (en) 1991-05-08
CA2019798C (en) 2001-03-20
JP2927893B2 (ja) 1999-07-28
US5100797A (en) 1992-03-31
DK0406211T3 (da) 1994-05-02
EP0406211B1 (en) 1994-03-30

Similar Documents

Publication Publication Date Title
BR8804402A (pt) Absorvente higienico
BR8503456A (pt) Absorvente higienico
DK317287D0 (da) Reduktase-inhibitorer
ES2063329T3 (es) Inhidores de fucosidasa.
NO904210D0 (no) Syntese av hydrokarbylaminer.
MX9100998A (es) Novedosos inhibidores de escualen sintetasa
FI101796B1 (fi) Uusia -glukosidaasi-inhibiittoreita
FI925144A (fi) Anvaendning av inhibitorer foer faergutvecklingen i kromogena bestaemningar
ES2023151B3 (es) Derivados de p-hidroxicinamamida e inhibidor de melanina que los contiene.
IT8822714A0 (it) Derivati di alcool n eterociclico.
MX9203383A (es) Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen.
IT8521657A0 (it) 1-(2-pirimidinil)-piperazinilderivati di 1-pirrolidin-2-oni psicogeriatrici.
IT1231914B (it) Inibitore della sintesi proteica
KR900003361U (ko) 냉장고의 탈취장치
DK165203C (da) Instrumentskab
DK0411624T3 (da) Saccharidderivater af protocatechualdehyl
KR900003367U (ko) 냉장고의 탈취장치
IT1225761B (it) Inibitore della sintesi proteica
KR920009913U (ko) 드롭테스터의 드롭유니트
MX174312B (es) Sintesis de 4-metil tiazola
KR910012201U (ko) 냉장고의 테이블 장치
KR900019062U (ko) 냉장고의 도어힌지용 붓슈구조체
KR880011574U (ko) 냉장쌀통
IT8820405A0 (it) Sintesi di trifluorometilisossazoli.
BR8401862A (pt) Armario sanitario

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 406211

Country of ref document: ES